Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders (Q37073677)

18 August 2017

1 reference

title

Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders (English)

1 reference

18 August 2017

0 references

Beau M Ances

1

0 references

Ronald Ellis

object named as

Ronald J Ellis

series ordinal

4

0 references

Scott Letendre

series ordinal

2

object named as

Scott L Letendre

1 reference

18 August 2017

Terry Alexander

3

1 reference

18 August 2017

1 February 2008

1 reference

International Review of Psychiatry

18 August 2017

1 reference

18 August 2017

20

1 reference

18 August 2017

89-93

1 reference

18 August 2017

1

1 reference

Valproic acid does not affect markers of human immunodeficiency virus disease progression

18 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Antiretroviral therapy in HIV infection: are neurologically active drugs important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Lithium ameliorates HIV-gp120-mediated neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Effect of lithium in murine immunodeficiency virus infected animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway. Implications for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

The impact of HIV-associated neuropsychological impairment on everyday functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Suppression of human immunodeficiency virus replication in human brain tissue by nucleoside reverse transcriptase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Lithium improves HIV-associated neurocognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Human immunodeficiency virus-associated dementia: an evolving disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Drug treatment of depression in HIV-positive patients : safety considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

The impact of efflux transporters in the brain on the development of drugs for CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

Clinical implications of CNS penetration of antiretroviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877670

10.1080/09540260701877670

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18240065